BMBowen Ma

Bowen Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bowen Ma has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Wai-Lung Ng

    Guangdong‐Hong Kong‐Macao Joint Laboratory for New Drug Screening School of Pharmacy The Chinese University of Hong Kong Hong Kong China

    6 shared publications
  • Tongyang Xu

    The Chinese University of Hong Kong

    3 shared publications
  • Yunpeng Huang

    Guangdong‐Hong Kong‐Macao Joint Laboratory for New Drug Screening School of Pharmacy The Chinese University of Hong Kong Hong Kong China

    3 shared publications
  • Haixing Xu

    Guangdong‐Hong Kong‐Macao Joint Laboratory for New Drug Screening School of Pharmacy The Chinese University of Hong Kong Hong Kong China

    2 shared publications
  • Jialin Liu

    State Key Laboratory of Medical Proteomics National Center for Protein Sciences (Beijing) Beijing China

    2 shared publications
  • Khadija Shahed Khan

    School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong

    2 shared publications

Latest Publications

  • Open Access

    Proximity‐Induced Protein Deglycosylation by Endogenous O‐GlcNAcase

    by Haixing Xu, Bowen Ma, Yunpeng Huang, Jialin Liu, Billy Wai‐Lung Ng

    O‐GlcNAcylation is an important post‐translational modification that regulates numerous cellular processes, yet tools enabling selective removal of O‐GlcNAc from individual proteins via endogenous O‐GlcNAcase (OGA) in living cells remain limited. Here, we report De‐O‐GlcNAcylation‐targeting chimeras (DOGTACs), a chemically induced proximity strategy that selectively reduces O‐GlcNAc from target proteins by recruiting endogenous OGA. Initial designs incorporating potent competitive OGA inhibitors efficiently engaged OGA but failed to induce de‐O‐GlcNAcylation, revealing that catalytic competence is essential for productive proximity‐driven editing. By attenuating inhibitor potency while retaining OGA engagement, we developed optimized DOGTACs that promote concentration‐ and time‐dependent, target‐specific de‐O‐GlcNAcylation in living cells without perturbing global O‐GlcNAc levels. Furthermore, we successfully applied DOGTAC to additional target proteins including FKBP12 F36V fused proteins and endogenous CK2α across different cell lines. Besides, we found DOGTAC (R)‐C4 treatment could reduce the stability of FKBP12 F36V fused‐NUP98‐KDM5A in cells. Collectively, this work established attenuated competitive inhibitors as recruitment modules for catalytic enzyme engagement and a novel strategy, DOGTAC, for targeted de‐O‐GlcNAcylation via endogenous OGA recruitment in living cells.

  • Open Access

    Proximity‐Induced Protein Deglycosylation by Endogenous O‐GlcNAcase

    by Haixing Xu, Bowen Ma, Yunpeng Huang, Jialin Liu, Billy Wai‐Lung Ng

    O‐GlcNAcylation is an important post‐translational modification that regulates numerous cellular processes, yet tools enabling selective removal of O‐GlcNAc from individual proteins via endogenous O‐GlcNAcase (OGA) in living cells remain limited. Here, we report De‐O‐GlcNAcylation‐targeting chimeras (DOGTACs), a chemically induced proximity strategy that selectively reduces O‐GlcNAc from target proteins by recruiting endogenous OGA. Initial designs incorporating potent competitive OGA inhibitors efficiently engaged OGA but failed to induce de‐O‐GlcNAcylation, revealing that catalytic competence is essential for productive proximity‐driven editing. By attenuating inhibitor potency while retaining OGA engagement, we developed optimized DOGTACs that promote concentration‐ and time‐dependent, target‐specific de‐O‐GlcNAcylation in living cells without perturbing global O‐GlcNAc levels. Furthermore, we successfully applied DOGTAC to additional target proteins including FKBP12 F36V fused proteins and endogenous CK2α across different cell lines. Besides, we found DOGTAC (R)‐C4 treatment could reduce the stability of FKBP12 F36V fused‐NUP98‐KDM5A in cells. Collectively, this work established attenuated competitive inhibitors as recruitment modules for catalytic enzyme engagement and a novel strategy, DOGTAC, for targeted de‐O‐GlcNAcylation via endogenous OGA recruitment in living cells.

  • Open Access

    Chemically Induced Proximity for Targeted Protein O- GlcNAcylation

    by Bowen Ma, Tongyang Xu, Zhihao Guo, Billy Wai-Lung Ng

    Conspectus: O-GlcNAcylation is a ubiquitous post-translational modification across the mammalian proteome, yet determining how individual O-GlcNAcylation events control specific protein functions remains a central challenge. The O-GlcNAc cycle is governed by two enzymes: O-GlcNAc transferase (OGT), which installs O-GlcNAc, and O-GlcNAcase (OGA), which removes it. Because these enzymes act on thousands of proteins, conventional methods, such as pharmacological inhibition of OGT or OGA, produce broad cellular effects that are difficult to assign to individual substrates. This gap has motivated the development of targeted O-GlcNAcylation strategies, including genetically encoded and chemical biology tools, which have shown that O-GlcNAc can be selectively installed on defined proteins to interrogate protein-specific O-GlcNAc functions. This Account describes the development of O-GlcNAc TArgeting Chimeras, or OGTACs, as chemical tools for targeted O-GlcNAc installation. OGTACs are bifunctional molecules that can recruit OGT to a specific protein of interest. Specifically, an OGTAC consists of an OGT-engaging element, a linker, and a target-recognition motif, which together bring OGT into proximity with a selected substrate. Our studies show that chemically induced proximity can redirect OGT toward selected proteins, thereby creating targeted O-GlcNAc writing that can partially bypass TPR-domain-mediated substrate recognition under engineered recruitment conditions. A central lesson is that productive O-GlcNAc writing requires not only recruitment, but also proper ternary-complex formation and noninhibitory OGT engagement. Moreover, the target-recognition motif determines the targetable protein space and achievable selectivity of the platform. By linking local O-GlcNAc installation to changes in protein turnover, signaling, and transcriptional output, OGTACs provide a conceptual framework for using induced proximity to modulate protein functions.

  • Open Access

    Lactone-to-Lactam Editing Alters the Pharmacology of Bilobalide

    by Xiaoding Jiang, Xu He, Jonathan Wong, Stephan Scheeff, Sam Chun-Kit Hau, Tak Hin Wong, Yao Qin, Chi Hang Fan, Bowen Ma, Ngai Lam Chung, et al.

    Precise transformations of natural products (NPs) can fine-tune their physicochemical properties while preserving inherently complex and evolutionarily optimized parent scaffolds. Here, we report an unprecedented lactone-to-lactam transformation on bilobalide, thus improving its stability and paving the way for biological exploration of previously inaccessible chemical space that is highly representative of the parent structure. This late-stage molecular editing of bilobalide enables facile access to a unique library of lactam analogues with altered pharmacology. Through phenotypic screening, we identify BB10 as a hit compound with unexpected inhibition of ferroptotic cell death. We further reveal that BB10 suppresses ferroptosis by restoring the expression of glutathione peroxidase 4 (GPX4) in brain cells. This study highlights that even subtle changes on NP scaffolds can confer new pharmacological properties, inspiring the exploration of simple yet critical transformations on complex NPs.


  • Open Access

    Targeted Protein O-GlcNAcylation Using Bifunctional Small Molecules

    by Bowen Ma, Khadija Shahed Khan, Tongyang Xu, Josefina Xeque Amada, Zhihao Guo, Yunpeng Huang, Yu Yan, Henry Lam, Alfred Sze-Lok Cheng, Billy Wai-Lung Ng

    Protein O-linked β-N-acetylglucosamine modification (O-GlcNAcylation) plays a crucial role in regulating essential cellular processes. The disruption of the homeostasis of O-GlcNAcylation has been linked to various human diseases, including cancer, diabetes, and neurodegeneration. However, there are limited chemical tools for protein- and site-specific O-GlcNAc modification, rendering the precise study of the O-GlcNAcylation challenging. To address this, we have developed heterobifunctional small molecules, named O-GlcNAcylation TArgeting Chimeras (OGTACs), which enable protein-specific O-GlcNAcylation in living cells. OGTACs promote O-GlcNAcylation of proteins such as BRD4, CK2α, and EZH2 in cellulo by recruiting FKBP12F36V-fused O-GlcNAc transferase (OGT), with temporal, magnitude, and reversible control. Overall, the OGTACs represent a promising approach for inducing protein-specific O-GlcNAcylation, thus enabling functional dissection and offering new directions for O-GlcNAc-targeting therapeutic development.


  • Open Access

    Targeted Protein O-GlcNAcylation Using Bifunctional Small Molecules

    by Bowen Ma, Khadija Shahed Khan, Tongyang Xu, Josefina Xeque Amada, Zhihao Guo, Yu Yan, Alfred Sze-Lok Cheng, Billy Wai-Lung Ng

    Protein O-linked β- N -acetylglucosamine modification (O-GlcNAcylation) plays a crucial role in regulating essential cellular processes. The disruption of O-GlcNAcylation homeostasis has been linked to various human diseases, including cancer, diabetes, and neurodegeneration. However, there are limited chemical tools for protein- and site-specific O-GlcNAc modification, rendering the precise study of O-GlcNAcylation challenging. To address this, we have developed first-in-class heterobifunctional small molecules, named O-GlcNAcylation targeting chimeras (OGTACs), which enable protein-specific O-GlcNAcylation in cells. OGTACs promote O-GlcNAcylation of proteins such as BRD4, CK2α, and EZH2 in cellulo by recruiting O-GlcNAc transferase (OGT), with temporal and magnitude control. Mass spectrometry data revealed that OGTACs induced site-selective O-GlcNAcylation of BRD4. Overall, OGTACs represent a promising approach for inducing protein-specific O-GlcNAcylation, thus enabling functional dissection and offering new directions for O-GlcNAc-targeting therapeutic development.